Business Description
Advanced Oncotherapy PLC
NAICS : 531190
ISIN : GB00BD6SX109
Description
Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -69.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-EBIT | -7.28 | |||||
| EV-to-Forward-Revenue | 0.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advanced Oncotherapy PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | -0.071 | ||
| Beta | 0 | ||
| Volatility % | 140.71 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (£) | 0 | ||
| 20-Day SMA (£) | 0.01925 | ||
| 12-1 Month Momentum % | -69.2 | ||
| 52-Week Range (£) | 0.0175 - 0.087 | ||
| Shares Outstanding (Mil) | 542.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Advanced Oncotherapy PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Advanced Oncotherapy PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Advanced Oncotherapy PLC Frequently Asked Questions
What is Advanced Oncotherapy PLC(LSE:AVO)'s stock price today?
The current price of LSE:AVO is £0.02. The 52 week high of LSE:AVO is £0.09 and 52 week low is £0.02.
When is next earnings date of Advanced Oncotherapy PLC(LSE:AVO)?
The next earnings date of Advanced Oncotherapy PLC(LSE:AVO) is .
Does Advanced Oncotherapy PLC(LSE:AVO) pay dividends? If so, how much?
Advanced Oncotherapy PLC(LSE:AVO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers